mouse |
LD50 |
intraperitoneal |
800mg/kg (800mg/kg) |
? |
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 238, Pg. 92, 1960. |
mouse |
LD50 |
intravenous |
165mg/kg (165mg/kg) |
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) |
Journal of Pharmacology and Experimental Therapeutics. Vol. 127, Pg. 66, 1959. |
mouse |
LD50 |
oral |
1800mg/kg (1800mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Arzneimittel-Forschung. Drug Research. Vol. 12, Pg. 340, 1962. |
rabbit |
LD50 |
intravenous |
124mg/kg (124mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: REGIDITY |
International Journal of Neuropharmacology. Vol. 5, Pg. 305, 1966. |
rat |
LD50 |
intraperitoneal |
450mg/kg (450mg/kg) |
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Pharmacology and Experimental Therapeutics. Vol. 127, Pg. 66, 1959. |
rat |
LD50 |
intravenous |
450mg/kg (450mg/kg) |
? |
Psychopharmacology Service Center, Bulletin. Vol. 2, Pg. 17, 1963. |
rat |
LD50 |
oral |
1320mg/kg (1320mg/kg) |
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Pharmacology and Experimental Therapeutics. Vol. 127, Pg. 66, 1959. |